Expert Perspective

Update on Migraine Prevention 2023

Author and Disclosure Information

 

The goal of preventive medications is to decrease the frequency, severity, and duration of migraine attacks. Effective treatment can increase responsiveness to acute migraine therapy and improve the quality of life in patients suffering from migraine. Every patient is different and thus the side effects they experience vary. With time and patience, most patients find the relief from migraine they have been desperately seeking through the preventive medicines discussed above. This is a good time to have migraine, if you can get in to see a knowledgeable doctor and your insurance company cooperates. When I started my neurology practice 51 years ago, we had few preventives, and none approved by the FDA. Now we have several older, approved preventives—4 newer mAbs, and 2 newer gepants—as well as several devices, which we will discuss in the future.

Pages

Recommended Reading

Late response to CGRP monoclonal antibodies is frequent in migraine
Migraine ICYMI
Eptinezumab lowers monthly migraine days in patients with multiple treatment failures
Migraine ICYMI
Galcanezumab shows sustained response in episodic, chronic, and treatment-resistant migraine
Migraine ICYMI
Migraine: CGRP-mAb class switch beneficial among nonresponders or those experiencing gradual loss of efficacy
Migraine ICYMI
Serum alpha-CGRP level as a potential biomarker in chronic migraine
Migraine ICYMI
COVID-19 history worsens clinical course of migraine
Migraine ICYMI
Migraine raises severity of vasomotor symptoms in midlife women
Migraine ICYMI
Meta-analysis elucidates bidirectional association between psoriasis and migraine
Migraine ICYMI
Maternal migraine raises risk for childhood cancers in offspring
Migraine ICYMI
Omega-3 supplementation may improve inflammatory markers in episodic migraine
Migraine ICYMI